Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia. (Q53672562)

17 May 2018

title

Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia. (English)

1 reference

17 May 2018

Erratum: Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia

1 reference

1 reference

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/TPJ.2016.86

author

Daniel Sinnett

14

1 reference

17 May 2018

author name string

M Krajinovic

1

1 reference

17 May 2018

J Elbared

2

1 reference

17 May 2018

S Drouin

3

1 reference

17 May 2018

L Bertout

4

1 reference

17 May 2018

A Rezgui

5

1 reference

17 May 2018

M Ansari

6

1 reference

17 May 2018

M-J Raboisson

7

1 reference

17 May 2018

S E Lipshultz

8

1 reference

17 May 2018

L B Silverman

9

1 reference

17 May 2018

S E Sallan

10

1 reference

17 May 2018

D S Neuberg

11

1 reference

17 May 2018

J L Kutok

12

1 reference

17 May 2018

C Laverdière

13

1 reference

17 May 2018

G Andelfinger

15

1 reference

17 May 2018

publication date

8 September 2015

1 reference

17 May 2018

The Pharmacogenomics Journal

published in

1 reference

17 May 2018

volume

16

1 reference

17 May 2018

issue

6

1 reference

17 May 2018

page(s)

530-535

1 reference

17 May 2018

Anthracycline cardiotoxicity in children

cites work

1 reference

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Anthracycline associated cardiotoxicity in survivors of childhood cancer

21 January 2018

1 reference

21 January 2018

1 reference

Doxorubicin pathways: pharmacodynamics and adverse effects

21 January 2018

1 reference

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

21 January 2018

1 reference

Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer

21 January 2018

1 reference

Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood

21 January 2018

1 reference

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

21 January 2018

1 reference

Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.

21 January 2018

1 reference

Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia

21 January 2018

1 reference

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

21 January 2018

1 reference

Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institut

21 January 2018

1 reference

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).

21 January 2018

1 reference

ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.

21 January 2018

1 reference

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

21 January 2018

1 reference

Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Role of NOS3 DNA variants in externalizing behavioral problems observed in childhood leukemia survivors

21 January 2018

1 reference

Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach

21 January 2018

1 reference

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

21 January 2018

1 reference

Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.

21 January 2018

1 reference

Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted mice

21 January 2018

1 reference

Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.

21 January 2018

1 reference

Differential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in mice

21 January 2018

1 reference

The role of NOS in heart failure: lessons from murine genetic models

21 January 2018

1 reference

Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase

21 January 2018

1 reference

Endothelial nitric oxide synthase single nucleotide polymorphism and left ventricular function in early chronic kidney disease

21 January 2018

1 reference

Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children.

21 January 2018

1 reference

Pharmacogenetics of target genes across doxorubicin disposition pathway: a review

21 January 2018

1 reference

Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin

21 January 2018

1 reference

Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21,068 subjects

21 January 2018

1 reference

The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage

21 January 2018

1 reference

Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart

21 January 2018

1 reference

The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides

21 January 2018

1 reference

Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes.

21 January 2018

1 reference

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data

21 January 2018

1 reference

Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity

21 January 2018

1 reference

Transesophageal Echocardiography

21 January 2018

1 reference

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

12 December 2020

Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.

1 reference

12 December 2020

Molecular mechanism of cGMP-mediated smooth muscle relaxation

1 reference

12 December 2020

Acute effects of nitric oxide and cyclic GMP on human myocardial contractility

1 reference

12 December 2020

Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature

1 reference

12 December 2020

ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation

1 reference

12 December 2020

Anthracycline-induced cardiotoxicity

1 reference

12 December 2020

Identifiers

DOI

10.1038/TPJ.2015.63

1 reference

17 May 2018

release_gcuptr44svah7ajfktufyetdwy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gcuptr44svah7ajfktufyetdwy

24 November 2022

mapped directly with Wikidata item

1 reference

17 May 2018